QIAGEN
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.About QGEN
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.
CEOThierry L. Bernard
CEOThierry L. Bernard
Employees5,765
Employees5,765
HeadquartersVenlo, Limburg
HeadquartersVenlo, Limburg
Founded1996
Founded1996
Employees5,765
Employees5,765
QGEN Key Statistics
Market cap10.17B
Market cap10.17B
Price-Earnings ratio27.48
Price-Earnings ratio27.48
Dividend yield0.53%
Dividend yield0.53%
Average volume1.08M
Average volume1.08M
High today$47.16
High today$47.16
Low today$46.70
Low today$46.70
Open price$46.82
Open price$46.82
Volume1.04M
Volume1.04M
52 Week high$51.88
52 Week high$51.88
52 Week low$37.63
52 Week low$37.63
QGEN News
TipRanks 6h
Qiagen N.V. Announces Voting Rights Notification by AFMElevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Simply Wall St 2d
Why Qiagen Is Up 6.6% After FDA Clearance and Raised Sales GuidanceIn early October 2025, Qiagen announced the global launch of the FDA-cleared QIAstat-Dx Rise syndromic testing system and expanded its next-generation sequencin...
TipRanks 6d
Qiagen price target lowered to $53 from $55 at BarclaysBarclays analyst Catherine Ramsey Schulte lowered the firm’s price target on Qiagen (QGEN) to $53 from $55 and keeps an Overweight rating on the shares as part...
Analyst ratings
58%
of 24 ratingsBuy
41.7%
Hold
58.3%
Sell
0%
People also own
Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.